Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444645) titled 'PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).

Primary Sponsor: M.D. Anderson Cancer Center

Condition: Tumor Liver

Intervention: Device: Y90 Microsphere Therapy

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: August 1, 2026

Target Sample Size: 20

Countries of Recruitme...